XSWX:STMN (Switzerland)
Business Description
Straumann Holding AG
NAICS : 339112
Peter Merian-Weg 12, Basel, CHE, 4002
Compare
Compare
Traded in other countries / regions
QS51.Germany
•
STMN.Mexico
•
STMN.Switzerland
•
0QMV.UK
•
SAUHF.USA
Description
Straumann is an established global leader in aesthetic dentistry, with a comprehensive offering of dental supplies and equipment. These include instruments, adhesives, implants, biomaterials, CAD/CAM equipment, prosthetics and orthodontics. Straumann's core focus and competitive advantage are within the implant dentistry market, in which Straumann has cornered more than one-quarter of the CHF 5 billion market. The company sells premium implants globally under the Straumann brand, alongside its flanker brands which target the lower end of the market (Anthogyr, Medentika, Neodent, NUVO, Warantec).
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.25 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | 1.18 | |||||
| Interest Coverage | 31.52 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 10.7 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.8 | |||||
| 3-Year EBITDA Growth Rate | 15.4 | |||||
| 3-Year EPS without NRI Growth Rate | 13 | |||||
| 3-Year FCF Growth Rate | 37.7 | |||||
| 3-Year Book Growth Rate | 7.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 86.13 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 12.35 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.06 | |||||
| 9-Day RSI | 59.65 | |||||
| 14-Day RSI | 60.32 | |||||
| 6-1 Month Momentum % | -22.05 | |||||
| 12-1 Month Momentum % | -33.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.72 | |||||
| Quick Ratio | 2.27 | |||||
| Cash Ratio | 1.57 | |||||
| Days Inventory | 178.08 | |||||
| Days Sales Outstanding | 59.28 | |||||
| Days Payable | 185.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.52 | |||||
| Dividend Payout Ratio | 0.23 | |||||
| 3-Year Dividend Growth Rate | 6.6 | |||||
| Forward Dividend Yield % | 0.52 | |||||
| 5-Year Yield-on-Cost % | 0.78 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 76.17 | |||||
| Operating Margin % | 26.56 | |||||
| Net Margin % | 19.59 | |||||
| ROE % | 29.23 | |||||
| ROA % | 14.26 | |||||
| ROIC % | 28.02 | |||||
| ROC (Joel Greenblatt) % | 68.99 | |||||
| ROCE % | 21.4 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 51.95 | |||||
| Forward PE Ratio | 39.22 | |||||
| PE Ratio without NRI | 51.95 | |||||
| Shiller PE Ratio | 103.77 | |||||
| Price-to-Owner-Earnings | 39.65 | |||||
| PEG Ratio | 6.18 | |||||
| PS Ratio | 10.18 | |||||
| PB Ratio | 13.72 | |||||
| Price-to-Tangible-Book | 23.97 | |||||
| Price-to-Free-Cash-Flow | 46.84 | |||||
| Price-to-Operating-Cash-Flow | 36.73 | |||||
| EV-to-EBIT | 41.09 | |||||
| EV-to-Forward-EBIT | 33.97 | |||||
| EV-to-EBITDA | 33.99 | |||||
| EV-to-Forward-EBITDA | 28.64 | |||||
| EV-to-Revenue | 10.05 | |||||
| EV-to-Forward-Revenue | 8.79 | |||||
| EV-to-FCF | 46.24 | |||||
| Price-to-Projected-FCF | 4.56 | |||||
| Price-to-DCF (Earnings Based) | 1.64 | |||||
| Price-to-DCF (FCF Based) | 2.11 | |||||
| Price-to-Median-PS-Value | 1.33 | |||||
| Price-to-Peter-Lynch-Fair-Value | 6.21 | |||||
| Price-to-Graham-Number | 7.44 | |||||
| Price-to-Net-Current-Asset-Value | 368.43 | |||||
| Earnings Yield (Greenblatt) % | 2.43 | |||||
| Forward Rate of Return (Yacktman) % | 9.52 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 2,021.903 | ||
| EPS (TTM) (CHF) | 2.482 | ||
| Beta | 1.19 | ||
| Volatility % | 38.03 | ||
| 14-Day RSI | 60.32 | ||
| 14-Day ATR (CHF) | 4.502613 | ||
| 20-Day SMA (CHF) | 123.64 | ||
| 12-1 Month Momentum % | -33.97 | ||
| 52-Week Range (CHF) | 97.26 - 210.8 | ||
| Shares Outstanding (Mil) | 158.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Straumann Holding AG Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||